
    
      This is a 12-week, prospective double-blinded, randomized, multicenter study of placebo, 120
      Unit, and 240 unit of botulinum toxin A ( Dysport ® ) injection for patient with a diagnosis
      of Migraine without aura according to International Headache Society criteria. It is designed
      to evaluate the efficacy, safety, tolerability and optimum dose of Botulinum toxin type A
      (Dysport ®)injection for migraine without aura prophylaxis.
    
  